StockDriftsStockDriftsBodytech Med (206640) has 3 disclosed insider purchases and 3 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩609M ($423K) in reported transaction value. The earliest filing StockDrifts holds for Bodytech Med is dated 2024-01-01; the most recent is 2026-04-06. Across these filings the average return since disclosure is +7.99%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | BUY | Market Buy | 장덕환 Deok-Hwan Jang | Managing Director | 4.0K | ₩10,520 | +13.3% | ₩42M ($29K) |
| 2026-04-06 | BUY | 수증 | 최규리 Gyuri Choi | moving | 1.2M | ₩10,520 | +13.3% | ₩12.6B ($8.8M) |
| 2026-04-06 | SELL | 증여 | 최의열 Choi Eui-yeol | CEO | -2.4M | ₩10,520 | -13.3% | ₩25.2B ($17.5M) |
| 2026-01-28 | BUY | Market Buy | 장덕환 Deok-Hwan Jang | Managing Director | 3.0K | ₩13,110 | +3.7% | ₩39M ($27K) |
| 2026-01-27 | BUY | Market Buy | 장덕환 Deok-Hwan Jang | Managing Director | 3.0K | ₩12,850 | +5.8% | ₩39M ($27K) |
| 2025-08-13 | SELL | Market Sell | 남기봉 Nam Gi-bong | moving | -18.0K | ₩14,240 | +4.5% | ₩256M ($178K) |
| 2025-06-19 | SELL | Market Sell | 남기봉 Nam Gi-bong | moving | -2.0K | ₩15,100 | +9.9% | ₩30M ($21K) |
| 2025-06-18 | SELL | Market Sell | 남기봉 Nam Gi-bong | moving | -13.3K | ₩15,220 | +10.6% | ₩203M ($141K) |
| 2025-03-26 | SELL | 증여 | 남기봉 Nam Gi-bong | moving | -80.0K | ₩15,620 | +12.9% | ₩1.2B ($868K) |
| 2024-01-09 | BUY | 기타 | 박대균 Park Dae-gyun | moving | 1.1K | ₩19,400 | -29.9% | ₩21M ($15K) |
| 2024-01-01 | BUY | 신규선임 | 김진수 Jinsu Kim | moving | 1.6K | ₩20,300 | -33.0% | ₩32M ($22K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.